Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

The study has also proposed Nodal Cancer Index (NCI ... by systemic chemotherapy is the standard of care for advanced ovarian cancers. In recent times, intraperitoneal chemotherapy has added an ...

Malla Reddy Narayana Hospital, Hyderabad is a premier cancer care centre in Telangana, announced a remarkable medical ...

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival ...

"They said, and you also have peritoneal carcinomatosis," Baker said. "I looked at them and said, 'You're speaking Spanish to me. I don't know what that is!'" It was ovarian cancer, stage 4.

Ovarian cancer is naturally resistant to chemotherapy, so its presence anywhere is difficult to combat. Ovarian cancer tends to metastasize through peritoneal fluid into the peritoneal cavity ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has surged by 6.64%, which has investors questioning if this is right time ...

As shown in Figure 2, peritoneal tissues ... to intravenous chemotherapy produces significantly longer progression-free and overall survival in ovarian cancer patients with small tumors (<1 ...

Professor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that he proved the effect of improving the survival rate of advanced ovarian ...

who had previously undergone two lines of chemotherapy at other institute came to the Cancer Center of Malla Reddy Narayana Hospital, he was diagnosed with Primary Peritoneal Ewing's Sarcoma ...